Improved Profitability
EBITDA before exceptional items increased 5% to CHF 679 million for FY2025; EBITDA margin before exceptional items improved by 180 basis points to 17.8% (from 16.0% in 2024). Q4 EBITDA before exceptional items rose 10% with a margin of 17.1% (+240 bps YoY).
Strong Cash Generation and Conversion
Free cash flow increased 31% to CHF 273 million and free cash flow conversion improved to 42%, a 10 percentage point increase versus 2024, already exceeding the medium-term 40% target.
Sales Stability in Tough Environment
Reported full-year sales were CHF 3.9 billion and flat in local currency despite a negative currency translation effect of approximately -6% for the year; Q4 sales were CHF 1.0 billion (+1% in local currency).
Progress on Cost Savings Program
Investor Day program run-rate target CHF 80 million by end-2027: CHF 50 million achieved in 2025 (63% of target), including CHF 19 million in Q4 and CHF 22 million from procurement initiatives; restructuring charges were CHF 63 million (below prior expectation of CHF 75 million).
Innovation and R&D Momentum
Innovation sales increased to 18.8% of revenue in 2025 (from 16.9% in 2024); R&D investment maintained at ~3% of revenue; innovation pipeline earned over 30 industry/customer awards.
Sustainability Leadership and Emissions Reductions
SBTi-approved targets: absolute Scope 1 & 2 emissions reduction target of 47% and Scope 3 reduction of 28% vs 2019 base. Scope 1 & 2 emissions fell 11% to 0.43 million metric tons; renewable electricity share rose from 69% to 76%; Scope 3.1 fell 6% to 2.4 million metric tons. Achieved top 1% CDP leadership with A in climate change and forests, A- in water security.
Customer and Employee Engagement Improvements
Customer Net Promoter Score (cNPS) rose to 50 from 45 (top-quartile vs peers). Employee Net Promoter Score (eNPS) increased to 37 from 34, employee participation 88% and engagement 87% (top quartile); safety improved with DART rate down to 0.13 from 0.17.
Segment-Level Outperformance (Catalysts & Care Chemicals)
Catalysts: Q4 sales +5% in local currency; EBITDA before exceptional items +22% to CHF 62 million, margin 23.4% (vs 18.8% prior). Care Chemicals: Q4 sales +1% LFL, EBITDA CHF 96 million (+7%), margin 18.3% (+220 bps).
Platform & Digital Adoption
CLARITY cloud-based catalyst management utilization nearly doubled to >220 customer plants and >800 users across 38 countries by end-2025, supporting customer operations and retention.
Shareholder Distribution
Proposing a stable distribution to shareholders of CHF 0.42 per share, reflecting confidence in cash generation and balance sheet management.